A client is acquiring a target with significant cost synergies expected to phase in over three years. How do you value these synergies in a merger model, and what discount rate do you use?
An advanced M&A Advisory question — expect it in final rounds and case-heavy interviews (IB, PE, Big-4 Transaction Services).
THE SHORT ANSWER
I model synergies as incremental EBITDA, net of implementation costs, phased over three years. To value them, I discount the after-tax synergy cash flows to present value using the acquirer's WACC, adjusted for the risk of realization—typically a higher discount rate (e.g., 12-15%) because synergies are uncertain. Alternatively, I apply a multiple to the steady-state synergy EBITDA (e.g., 8-10x) and discount back. I also consider synergy decay or one-time costs.
WHAT INTERVIEWERS LISTEN FOR
- ✓Phase synergies over 3 years
- ✓Net of implementation costs
- ✓Discount at WACC or higher rate
- ✓Multiple approach as alternative
COMMON MISTAKES
- ✗Using target's WACC for synergies
- ✗Ignoring phase-in timing or implementation costs
Reading isn't the same as answering under pressure.
Interviewers don't hand you the model answer — you deliver yours on a clock. Practice this and 1,000+ questions with AI feedback on every answer.
RELATED QUESTIONS
- Walk me through a DCF.
- What is the difference between Enterprise Value and Equity Value?
- Why might you use EV/Revenue instead of EV/EBITDA?
- How do you calculate WACC?
- A company trades at 8x EV/EBITDA versus a peer at 12x. Why the gap, and what would you check?
- What is a football field chart and how is it used?